InvestorsHub Logo

clambottler

02/28/21 7:03 AM

#149204 RE: kgromax #149202

KYGRO there are a few reasons the trial will fail. Among Them:

1. The SOC Standard of Care changed from the time they started.
Patients are now placed in prone position and predominantly provided HFNC which is high flow nasal canula.

But equally important is the steroids.

2. I think you will find many if not not most of the CYDY patients entered the trial before this new " SOC ".

3. FDA is looking at the data - and wants to take OUT the patients that were enrolled at a time PRIOR to this new SOC - on both arms.

4. So there are far too few patients.

Of course this is just my opinion

BUT what is NOT MY OPINION

5. CYDY DSMB Data Safety Monitoring Board SUGGESTED ANOTHER LOOK AT DATA for INFERIORITY - but apparently NADER said NO.

So their own DSMB is or was making recommendations that the CEO refused to follow.

But we all know how they blew the HIV BLA filing.......

So history here repeats ? ....


Anyway this is just my understanding at this time. DO not ask me ASK THE CEO write to him, call him, ask him.
Confirm the information I believe you will see it is 100% accurate but maybe I made a mistake.

I have sent he and his team questions, and received no reply.

Yes, I agree, this is an absolute failure you are correct.


. IS THERE ANY QUESTION WHY CYDY IS HIRING A PARALEGAL TO HELP SELL RESTRICTED SHARES ??? You bet your backside we know why.
.
.
. Good Luck to All ---

xxx.
xx.
x.

Dieselpro

02/28/21 7:58 AM

#149206 RE: kgromax #149202

They will sell shares into nasdaq after approval. Anyone would be a fool not to take some profit at $100 a share.

Maverick0408

02/28/21 9:37 AM

#149223 RE: kgromax #149202

I’d also be worried if I shorted at $2 or $3 not long ago! A quick question to the group - how many doses would US government purchase on EUA? They ordered 100k at over $300 million from Eli Lilly last week with a provision to go over 1 million for mild to moderate, when they already have quite a few drugs working and approved with those patient population. Although, we all know how good they work, as detailed by several physicians who are treating these patients everyday! ;) I predict ours would be the first EUA for severe to critical, and we will have over a $1 billion order from US government within a month from now.

JR30

02/28/21 10:09 AM

#149231 RE: kgromax #149202

This job posting is the ugly truth about Cytodyn.



Doesn't speak confidence about the pending CD12 trial. Does it.



The job posting shows a need to expand due to future growth. Couldn't be a better sign for confidence than hiring more people. Not ugly at all for investors, but maybe you meant shorters?

2020trader

02/28/21 5:59 PM

#149283 RE: kgromax #149202

25% down next week - IMO